MX9304931A - Anticonceptivos que contienen antiprogestogenos. - Google Patents
Anticonceptivos que contienen antiprogestogenos.Info
- Publication number
- MX9304931A MX9304931A MX9304931A MX9304931A MX9304931A MX 9304931 A MX9304931 A MX 9304931A MX 9304931 A MX9304931 A MX 9304931A MX 9304931 A MX9304931 A MX 9304931A MX 9304931 A MX9304931 A MX 9304931A
- Authority
- MX
- Mexico
- Prior art keywords
- phase
- regimen
- sequential
- daily
- contraceptive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen regímenes de anticonceptivos orales efectivos que contienen una fase antiprogestógenos combinada con una fase de progestógenos. Un régimen de anticonceptivos que tiene: una primera fase de 5-20, en especial 14, unidades de dosis secuenciales diarias que contienen un antiprogestógeno a una dosis diaria suficiente para inhibir la ovulación en la mujer, y una segunda fase de 10 a 25, especialmente 14, unidades de dosis diarias secuenciales que contienen un progestógenos a una dosis equivalente a 40-120 µg de desogestrel administrado oralmente. A la primera fase preferencialmente se añade un estrógeno como el 17ß-estradio (de 0.50 a 2.5mg diariamente) para permitir la posibilidad de hacer régimen secuencial. La presente invención también incluye un producto anticonceptivo (es decir, el paquete que contiene el régimen de dosis unitaria), y un proceso para fabricar este producto.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92202504 | 1992-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9304931A true MX9304931A (es) | 1994-08-31 |
Family
ID=8210854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9304931A MX9304931A (es) | 1992-08-14 | 1993-08-13 | Anticonceptivos que contienen antiprogestogenos. |
Country Status (4)
| Country | Link |
|---|---|
| AU (1) | AU4708993A (es) |
| MX (1) | MX9304931A (es) |
| WO (1) | WO1994004156A1 (es) |
| ZA (1) | ZA935617B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993021926A1 (en) * | 1992-05-06 | 1993-11-11 | Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
| US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
| US6506390B2 (en) | 1996-06-25 | 2003-01-14 | Akzo Nobel | Progestogen-anti-progestogen regimens |
| WO1997049407A1 (en) * | 1996-06-25 | 1997-12-31 | Akzo Nobel N.V. | Progestogen-anti-progestogen regimens |
| KR20010032056A (ko) * | 1997-11-14 | 2001-04-16 | 에프.지.엠. 헤르만스 ; 이.에이치. 리링크 | 황체 호르몬-항 황체 호르몬 투약법 |
| DE69934113T2 (de) * | 1998-05-22 | 2007-06-06 | Abbott Laboratories, Abbott Park | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen |
| US6632961B1 (en) | 1998-05-22 | 2003-10-14 | Abbott Laboratories | Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| DE60014358D1 (de) * | 1999-04-29 | 2004-11-04 | Akzo Nobel Nv | Verwendung von org 33245 in der kombinierten intermittierenden hormontherapie und empfängnisverhütung |
-
1993
- 1993-08-03 ZA ZA935617A patent/ZA935617B/xx unknown
- 1993-08-10 AU AU47089/93A patent/AU4708993A/en not_active Abandoned
- 1993-08-10 WO PCT/EP1993/002139 patent/WO1994004156A1/en active Application Filing
- 1993-08-13 MX MX9304931A patent/MX9304931A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA935617B (en) | 1994-03-07 |
| AU4708993A (en) | 1994-03-15 |
| WO1994004156A1 (en) | 1994-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4530839A (en) | Triphasic oral contraceptive | |
| KR920011514A (ko) | 프로게스토겐만을 함유하는 피임제 | |
| US4544554A (en) | Triphasic oral contraceptive | |
| US4616006A (en) | Triphasic oral contraceptive | |
| ES2116804T3 (es) | Preparado polifasico para la anticoncepcion basado en estrogenos naturales. | |
| KR960700727A (ko) | 호르몬 대체 치료(hormone replacement therapy) | |
| KR960706344A (ko) | 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne) | |
| PT99819B (pt) | Processo de fabrico de contraceptivos orais compreendendo progestogenio e estrogenio | |
| RU96115196A (ru) | Состав для контрацепции | |
| FI103951B1 (fi) | Ehkäisyjärjestelmä | |
| US3939264A (en) | Method for contraception by the administration of sequential contraceptive preparations | |
| SE7416039L (es) | ||
| FI924519A (fi) | Hormonaaliseen raskaudenehkäisyyn tarkoitettu ovulaation estävä valmiste | |
| US3795734A (en) | Cyclic regimen of hormone administration for contraception | |
| GB1384214A (en) | Oral contraceptive regimens and packaged unit dosage forms thereof | |
| Coutinho | Treatment of endometriosis with gestrinone (R-2323), a synthetic antiestrogen, antiprogesterone | |
| GB1209468A (en) | Packs of discrete dosage units for stimulating anovulatory cycles | |
| ES2397983T3 (es) | Procedimiento anticonceptivo oral multifásico de ciclo prolongado | |
| MX9304931A (es) | Anticonceptivos que contienen antiprogestogenos. | |
| NZ307178A (en) | Medicament for contraception; contains two, separately packed, sequential hormonal components | |
| JPS6429314A (en) | Medicine dosage | |
| BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
| NZ225699A (en) | Medicament packet: strip pack on flap | |
| RU2449796C9 (ru) | Фармацевтическая комбинация этинилэстрадиола и дроспиренона для использования в качестве контрацептива | |
| NZ504351A (en) | Contraceptive kit comprising progestogen and anti-progestogen and use in treating bleeding induced by a progestogen-only contraceptive regimen |